导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.74% | 986/1050 |
| 近一周 | -5.87% | 1090/1104 |
| 近一月 | -6.10% | 737/1102 |
| 近一季 | -1.30% | 300/1092 |
| 近半年 | -15.92% | 912/1070 |
| 近一年 | -27.83% | 976/1018 |
| 近两年 | -2.58% | 894/926 |
| 近三年 | -31.91% | 814/834 |
| 成立以来 | -24.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.89% 998/1070 |
-16.29% 1039/1101 |
- - |
- - |
| 2025 | -0.29% 933/1065 |
2.79% 565/1014 |
-3.35% 906/1038 |
6.90% 903/1050 |
-6.11% 747/1065 |
| 2024 | -7.21% 730/1011 |
-1.24% 385/960 |
-8.81% 820/983 |
11.37% 516/991 |
-7.48% 801/1011 |
| 2023 | -9.52% 313/952 |
5.35% 304/880 |
-8.30% 705/895 |
-0.27% 94/915 |
-6.08% 607/952 |
| 2022 | -20.37% 338/867 |
-21.13% 586/773 |
14.32% 138/806 |
-15.30% 583/845 |
4.26% 238/867 |
| 2021 | -12.92% 503/740 |
-7.19% 424/580 |
8.67% 394/659 |
-16.52% 634/704 |
3.43% 281/740 |
| 2020 | 80.06% 90/554 |
-0.64% 177/419 |
26.49% 174/466 |
17.44% 89/517 |
21.99% 103/554 |
| 2019 | 23.49% 323/410 |
27.44% 660/3053 |
-9.68% 2949/3201 |
2.58% 265/390 |
4.59% 352/410 |
| 2018 | -41.05% 278/349 |
- - |
-14.02% 2746/2983 |
-14.78% 2837/2970 |
-14.56% 2672/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华商消费行业股票 VS. 东吴新产业精选股票A(580008) |